发明申请
US20120208200A1 ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF
审中-公开
EDG5多态性V286A与II型糖尿病和静脉血栓形成/肺动脉栓塞的联合及其使用
- 专利标题: ASSOCIATION OF EDG5 POLYMORPHISM V286A WITH TYPE II DIABETES MELLITUS AND VENOUS THROMBOSIS/PULMONARY EMBOLISM AND THE USE THEREOF
- 专利标题(中): EDG5多态性V286A与II型糖尿病和静脉血栓形成/肺动脉栓塞的联合及其使用
-
申请号: US13457781申请日: 2012-04-27
-
公开(公告)号: US20120208200A1公开(公告)日: 2012-08-16
- 发明人: Detlef KOZIAN , Evi KOSTENIS , Karl-Ernst SIEGLER , Martina JACOBS , Jean-Francois DELEUZE , Sylvain RICARD , Sandrine MACE
- 申请人: Detlef KOZIAN , Evi KOSTENIS , Karl-Ernst SIEGLER , Martina JACOBS , Jean-Francois DELEUZE , Sylvain RICARD , Sandrine MACE
- 申请人地址: DE Frankfurt am Main
- 专利权人: SANOFI-AVENTIS DEUTSCHLAND GMBH
- 当前专利权人: SANOFI-AVENTIS DEUTSCHLAND GMBH
- 当前专利权人地址: DE Frankfurt am Main
- 优先权: EP02007879.6 20020409
- 主分类号: C12Q1/68
- IPC分类号: C12Q1/68 ; G01N33/566
摘要:
The present invention relates to a method of identifying an increase in risk for type II Diabetes mellitus, venous thrombosis, or pulmonary embolism in a subject, wherein the presence of an amino acid exchange at position 286 from valine (Val) to alanine (Ala) in the EDG5 protein in a biological sample taken from the subject.